Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ASCBQ OTCMKTS:EROX OTCMKTS:ETFM OTCMKTS:NANX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASCBQAscendia Brands$0.00$0.00▼$0.00N/AN/AN/AN/AEROXHuman Pheromone Sciences$0.00$0.00$0.00▼$0.13N/A3.313,574 shsN/AETFMFOMO$0.00$0.00$0.00▼$0.03$13.98M7.78203.35 million shs22 shsNANXNanophase Technologies$2.56$0.77▼$3.15$121.29M1.2240,418 shs85,351 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASCBQAscendia Brands0.00%0.00%0.00%0.00%0.00%EROXHuman Pheromone Sciences0.00%0.00%0.00%0.00%0.00%ETFMFOMO0.00%0.00%0.00%+25.00%-36.71%NANXNanophase Technologies0.00%0.00%0.00%0.00%+30.26%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASCBQAscendia BrandsN/AN/AN/AN/AN/AN/AN/AN/AEROXHuman Pheromone SciencesN/AN/AN/AN/AN/AN/AN/AN/AETFMFOMON/AN/AN/AN/AN/AN/AN/AN/ANANXNanophase TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASCBQAscendia Brands 0.00N/AN/AN/AEROXHuman Pheromone Sciences 0.00N/AN/AN/AETFMFOMO 0.00N/AN/AN/ANANXNanophase Technologies 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASCBQAscendia BrandsN/AN/AN/AN/AN/AN/AEROXHuman Pheromone SciencesN/AN/AN/AN/AN/AN/AETFMFOMON/AN/AN/AN/AN/AN/ANANXNanophase Technologies$37.30M0.00N/AN/A$0.04 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASCBQAscendia BrandsN/AN/A0.00N/AN/AN/AN/AN/AN/AEROXHuman Pheromone SciencesN/AN/A0.00∞N/AN/AN/AN/AN/AETFMFOMO-$70KN/A0.00∞N/AN/A-6.23%-148.02%N/ANANXNanophase Technologies-$4.39M$0.0586.67N/AN/A5.59%31.49%6.67%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASCBQAscendia BrandsN/AN/AN/AN/AN/AEROXHuman Pheromone SciencesN/AN/AN/AN/AN/AETFMFOMON/AN/AN/AN/AN/ANANXNanophase TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASCBQAscendia BrandsN/AN/AN/AEROXHuman Pheromone SciencesN/AN/AN/AETFMFOMON/AN/AN/ANANXNanophase TechnologiesN/A1.280.63Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASCBQAscendia BrandsN/AEROXHuman Pheromone SciencesN/AETFMFOMON/ANANXNanophase Technologies70.22%Insider OwnershipCompanyInsider OwnershipASCBQAscendia Brands49.76%EROXHuman Pheromone Sciences20.70%ETFMFOMO8.70%NANXNanophase Technologies5.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASCBQAscendia Brands324N/AN/ANot OptionableEROXHuman Pheromone Sciences3N/AN/ANot OptionableETFMFOMON/A5.59 billionN/ANot OptionableNANXNanophase Technologies6070.01 million66.44 millionNot OptionableEROX, ASCBQ, NANX, and ETFM HeadlinesRecent News About These CompaniesSolésence Announces Uplisting to NasdaqApril 7, 2025 | globenewswire.comNanophase targets record Q1 2025 revenue with 33% gross margins amid heightened demandMarch 27, 2025 | msn.comNanophase Technologies Corp. (NANX) Q4 2024 Earnings Call TranscriptMarch 27, 2025 | seekingalpha.comSolésence Reports Record Fourth Quarter and Full-Year 2024 Financial ResultsMarch 26, 2025 | globenewswire.comSolésence To Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference CallMarch 20, 2025 | globenewswire.comSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Solesence, Inc. f/k/a Nanophase Technologies Corporation (OTCQB: NANX) and Encourages Current NANX Shareholders to Contact the FirmMarch 18, 2025 | globenewswire.comSolésence Wins Best Prestige Finished Formula at the 2025 Cosmetics & Toiletries Allē Awards, Marking Third Consecutive WinMarch 13, 2025 | globenewswire.comSolésence Launches New Investor Relations WebsiteMarch 12, 2025 | globenewswire.comNanophase Tech rebrands as SolesenceMarch 7, 2025 | markets.businessinsider.comNanophase Technologies Rebrands as Solésence, Elevating the Future of Skin HealthMarch 7, 2025 | globenewswire.comNanophase Technologies: Continued Evidence Of A Sunny ForecastJanuary 16, 2025 | seekingalpha.comNanophase Technologies Corp.December 11, 2024 | wsj.comNanophase Technologies Corporation (PNK:NANX) Q3 2024 Earnings Call TranscriptNovember 5, 2024 | msn.comNanophase Technologies Corporation: Nanophase Reports Record Third Quarter Revenue and ProfitNovember 2, 2024 | finanznachrichten.deNanophase Technologies Corporation (NANX) Q3 2024 Earnings Call TranscriptNovember 2, 2024 | seekingalpha.comNanophase Technologies Reports Record Q3 Revenue and ProfitNovember 1, 2024 | markets.businessinsider.comNanophase Reports Record Third Quarter Revenue and ProfitOctober 30, 2024 | globenewswire.comNanophase Technologies Announces Third Quarter 2024 Financial Release and Conference Call DetailsOctober 24, 2024 | globenewswire.comAdvances in Nanoscale Manipulation Transform Electronic DevicesOctober 14, 2024 | msn.comNanophase Technologies Corp (NANX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...October 10, 2024 | finance.yahoo.comEROX, ASCBQ, NANX, and ETFM Company DescriptionsAscendia Brands OTCMKTS:ASCBQAscendia Brands, Inc. manufactures, markets, and distributes health and beauty care products in Canada and the United States. The company offers bath, baby, oral, skin, and hair care products. Its products include bath products, baby toiletries, deodorant and antiperspirant products, home permanent treatments, mouthwash products, portable breath sprays and drops, and manual toothbrushes. The company's brand portfolio comprises Calgon, the Healing garden, Lander, and Lander essentials. It sells its products through mass merchandisers, drug stores, supermarkets, and dollar store outlets. Ascendia Brands, Inc. was formerly known as Cenuco, Inc. and changed its name to Ascendia Brands, Inc. in May 2005. The company was founded in 1920 and is based in Hamilton, New Jersey. Ascendia Brands, Inc. is in reorganization.Human Pheromone Sciences OTCMKTS:EROX$0.0004 0.00 (0.00%) As of 09/26/2022Human Pheromone Sciences, Inc. engages in the research, development, manufacture, and marketing of consumer products containing synthetic human pheromones and other mood enhancing compounds in the United States and internationally. It provides a line of fragrance and toiletry products for men and women under the Natural Attraction trademark. The company also licenses its initial compounds and related technology, as well as sells its patented compounds to licensed customers to include these compounds as components in their products. In addition, it offers private label manufacturing services to licensed customers. Human Pheromone Sciences, Inc. distributes its products through distributors, as well as through the Web site, naturalattraction.com. The company was formerly known as EROX Corporation and changed its name to Human Pheromone Sciences, Inc. in May 1998. Human Pheromone Sciences, Inc. was founded in 1989 and is headquartered in San Jose, California.FOMO OTCMKTS:ETFM$0.0025 0.00 (0.00%) As of 07/15/2025FOMO Corp. focuses on incubation and acceleration business. The company invests in and advises emerging companies aligned with a growth mandate. It develops various direct investment and affiliations. The company was formerly known as 2050 Motors, Inc. FOMO Corp. was founded in 2012 and is based in Chicago, Illinois.Nanophase Technologies OTCMKTS:NANXNanophase Technologies Corporation, a science-driven company, develops, manufactures, and sells integrated family of nanomaterial technologies in the United States. It engages in engineered materials, formulation development, and commercial manufacturing. The company produces engineered nanomaterial products comprising antimony, bismuth, cerium, iron, and zinc oxide for use in a various markets, including surface finishing,exterior coatings, personal care, plastics, scratch resistant coatings, and textiles. It also provides skin care formulations with mineral-based UV protection under the under the Solésence brand; and advanced material products, including architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
